Re: Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes
|
7
|
Resverlogix Corp.
|
Aug 29, 2023 09:30AM
|
You have to go donny boy - what an embarrassment- lies lies & more lies - incompetent gold medal winner
|
1
|
Resverlogix Corp.
|
Sep 01, 2023 03:04PM
|
Re: You have to go donny boy - what an embarrassment- lies lies & more lies - incompetent gold medal winner
|
|
Resverlogix Corp.
|
Sep 01, 2023 05:52PM
|
Re: You have to go donny boy - what an embarrassment- lies lies & more lies - incompetent gold medal winner
|
|
Resverlogix Corp.
|
Sep 01, 2023 06:36PM
|
Rumour has it
|
2
|
Resverlogix Corp.
|
Sep 08, 2023 10:17AM
|
Re: Rumour has it
|
2
|
Resverlogix Corp.
|
Sep 11, 2023 01:17PM
|
Re: Rumour has it
|
1
|
Resverlogix Corp.
|
Sep 11, 2023 01:35PM
|
Re: Rumour has it
|
1
|
Resverlogix Corp.
|
Sep 11, 2023 03:22PM
|
Tell the board what you know Tada?
|
2
|
Resverlogix Corp.
|
Sep 11, 2023 03:45PM
|
Re: Rumour has it
|
6
|
Resverlogix Corp.
|
Sep 11, 2023 04:49PM
|
Re: Add one to the list
|
1
|
Zenith Epigenetics
|
Sep 13, 2023 01:27PM
|
wideout,Tada etc…
|
4
|
Resverlogix Corp.
|
Sep 13, 2023 02:19PM
|
This was the most Rec post over 4 years ago by Payzone
|
3
|
Zenith Epigenetics
|
Oct 24, 2023 07:03PM
|
Re: Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
|
1
|
Zenith Epigenetics
|
Oct 25, 2023 09:05PM
|
Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
|
1
|
Resverlogix Corp.
|
Oct 25, 2023 09:08PM
|
This so called “Expert Market”
|
1
|
Zenith Epigenetics
|
Oct 26, 2023 10:39AM
|
Re: Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
|
2
|
Resverlogix Corp.
|
Oct 26, 2023 11:05AM
|
Re: This so called “Expert Market”
|
|
Zenith Epigenetics
|
Oct 26, 2023 11:07AM
|
Re: ACCORDING TO "GlobalData" https://www.globalda...
|
1
|
Resverlogix Corp.
|
Oct 26, 2023 11:11AM
|
Re: Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
|
6
|
Resverlogix Corp.
|
Oct 26, 2023 12:50PM
|